SFS
ICPT

Sowell Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sowell Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-314
Closed -$8K – 3359
2020
Q4 		$8K Sell
314
-1,666
-84% -$55.2K ﹤0.01% 2139
2020
Q3 		$82K Sell
1,980
-77
-4% -$3.54K ﹤0.01% 1051
2020
Q2 		$99K Buy
2,057
+1,524
+286% +$118K 0.01% 973
2020
Q1 		$34K Sell
533
-122
-19% -$11K ﹤0.01% 1189
2019
Q4 		$81K Buy
655
+540
+470% +$48.3K 0.01% 978
2019
Q3 		$8K Buy
+115
New +$7.72K ﹤0.01% 1617

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Sowell Financial Services's ICPT Position: Q1 2021 in Review

Sowell Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 314 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in ICPT in Q3 2019 and held it in 6 quarters. The position peaked at $99K in Q2 2020. 152 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

  • Sowell Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 314 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2019 and held it in 6 quarters.
  • Sowell Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $99K in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.